Gene-Chemical Interaction Annotations Click to see Annotation Detail View
Object Symbol | Species | Term | Qualifier | Evidence | With | Reference | Notes | Source | Original Reference(s) | ARHGEF5 | Human | (1->4)-beta-D-glucan | multiple interactions | ISO | Arhgef5 (Mus musculus) | 6480464 | [perfluorooctane sulfonic acid co-treated with Cellulose] results in increased expression of ARHGEF5 mRNA | CTD | PMID:36331819 | ARHGEF5 | Human | 1,2-dimethylhydrazine | multiple interactions | ISO | Arhgef5 (Mus musculus) | 6480464 | Folic Acid inhibits the reaction [1 and 2-Dimethylhydrazine results in increased expression of ARHGEF5 mRNA] | CTD | PMID:22206623 | ARHGEF5 | Human | 17beta-estradiol | multiple interactions | ISO | Arhgef5 (Rattus norvegicus) | 6480464 | [bisphenol A co-treated with Estradiol] results in increased expression of ARHGEF5 mRNA | CTD | PMID:26496021 | ARHGEF5 | Human | 2,2',5,5'-tetrachlorobiphenyl | increases expression | ISO | Arhgef5 (Rattus norvegicus) | 6480464 | 2 more ... | CTD | PMID:23829299 | ARHGEF5 | Human | 2,3,7,8-tetrachlorodibenzodioxine | increases expression | ISO | Arhgef5 (Rattus norvegicus) | 6480464 | Tetrachlorodibenzodioxin results in increased expression of ARHGEF5 mRNA | CTD | PMID:21215274 and PMID:32109520 | ARHGEF5 | Human | 2,3,7,8-tetrachlorodibenzodioxine | decreases expression | ISO | Arhgef5 (Rattus norvegicus) | 6480464 | Tetrachlorodibenzodioxin results in decreased expression of ARHGEF5 mRNA | CTD | PMID:33387578 | ARHGEF5 | Human | 2,4-dinitrotoluene | affects expression | ISO | Arhgef5 (Rattus norvegicus) | 6480464 | 2 and 4-dinitrotoluene affects the expression of ARHGEF5 mRNA | CTD | PMID:21346803 | ARHGEF5 | Human | 2,6-dinitrotoluene | affects expression | ISO | Arhgef5 (Rattus norvegicus) | 6480464 | 2 and 6-dinitrotoluene affects the expression of ARHGEF5 mRNA | CTD | PMID:21346803 | ARHGEF5 | Human | 3-chloropropane-1,2-diol | increases expression | ISO | Arhgef5 (Rattus norvegicus) | 6480464 | alpha-Chlorohydrin results in increased expression of ARHGEF5 protein | CTD | PMID:34915118 | ARHGEF5 | Human | 4,4'-sulfonyldiphenol | multiple interactions | ISO | Arhgef5 (Mus musculus) | 6480464 | [bisphenol S co-treated with Tretinoin] results in decreased expression of ARHGEF5 mRNA | CTD | PMID:30951980 | ARHGEF5 | Human | 4,4'-sulfonyldiphenol | increases expression | ISO | Arhgef5 (Mus musculus) | 6480464 | bisphenol S results in increased expression of ARHGEF5 mRNA | CTD | PMID:30951980 | ARHGEF5 | Human | 4-hydroxyphenyl retinamide | increases expression | ISO | Arhgef5 (Mus musculus) | 6480464 | Fenretinide results in increased expression of ARHGEF5 mRNA | CTD | PMID:28973697 | ARHGEF5 | Human | 6-propyl-2-thiouracil | increases expression | ISO | Arhgef5 (Rattus norvegicus) | 6480464 | Propylthiouracil results in increased expression of ARHGEF5 mRNA | CTD | PMID:24780913 | ARHGEF5 | Human | all-trans-retinoic acid | multiple interactions | ISO | Arhgef5 (Mus musculus) | 6480464 | [bisphenol F co-treated with Tretinoin] results in decreased expression of ARHGEF5 mRNA and [bisphenol S co-treated with Tretinoin] results in decreased expression of ARHGEF5 mRNA | CTD | PMID:30951980 | ARHGEF5 | Human | alpha-Zearalanol | multiple interactions | ISO | Arhgef5 (Rattus norvegicus) | 6480464 | [Zeranol co-treated with perfluorooctanoic acid] results in decreased expression of ARHGEF5 mRNA | CTD | PMID:35163327 | ARHGEF5 | Human | ammonium chloride | affects expression | ISO | Arhgef5 (Rattus norvegicus) | 6480464 | Ammonium Chloride affects the expression of ARHGEF5 mRNA | CTD | PMID:16483693 | ARHGEF5 | Human | benzo[a]pyrene | increases expression | EXP | | 6480464 | Benzo(a)pyrene results in increased expression of ARHGEF5 mRNA | CTD | PMID:20064835 | ARHGEF5 | Human | bis(2-ethylhexyl) phthalate | increases expression | EXP | | 6480464 | Diethylhexyl Phthalate results in increased expression of ARHGEF5 mRNA | CTD | PMID:31163220 | ARHGEF5 | Human | bisphenol A | multiple interactions | ISO | Arhgef5 (Rattus norvegicus) | 6480464 | [bisphenol A co-treated with Estradiol] results in increased expression of ARHGEF5 mRNA | CTD | PMID:26496021 | ARHGEF5 | Human | bisphenol A | decreases expression | ISO | Arhgef5 (Rattus norvegicus) | 6480464 | bisphenol A results in decreased expression of ARHGEF5 mRNA | CTD | PMID:34947998 | ARHGEF5 | Human | bisphenol A | affects expression | ISO | Arhgef5 (Rattus norvegicus) | 6480464 | bisphenol A affects the expression of ARHGEF5 mRNA | CTD | PMID:30816183 more ... | ARHGEF5 | Human | bisphenol A | increases expression | ISO | Arhgef5 (Mus musculus) | 6480464 | bisphenol A results in increased expression of ARHGEF5 mRNA | CTD | PMID:30951980 and PMID:34585602 | ARHGEF5 | Human | bisphenol A | increases expression | ISO | Arhgef5 (Rattus norvegicus) | 6480464 | bisphenol A results in increased expression of ARHGEF5 mRNA | CTD | PMID:25181051 | ARHGEF5 | Human | bisphenol F | multiple interactions | ISO | Arhgef5 (Mus musculus) | 6480464 | [bisphenol F co-treated with Tretinoin] results in decreased expression of ARHGEF5 mRNA | CTD | PMID:30951980 | ARHGEF5 | Human | bisphenol F | increases expression | ISO | Arhgef5 (Mus musculus) | 6480464 | bisphenol F results in increased expression of ARHGEF5 mRNA | CTD | PMID:30951980 | ARHGEF5 | Human | butan-1-ol | multiple interactions | EXP | | 6480464 | [[Gasoline co-treated with 1-Butanol] results in increased abundance of [Particulate Matter co-treated with Polycyclic Aromatic Hydrocarbons]] which results in increased expression of ARHGEF5 mRNA | CTD | PMID:29432896 | ARHGEF5 | Human | cadmium dichloride | decreases expression | EXP | | 6480464 | Cadmium Chloride results in decreased expression of ARHGEF5 mRNA | CTD | PMID:38568856 | ARHGEF5 | Human | caffeine | affects phosphorylation | EXP | | 6480464 | Caffeine affects the phosphorylation of ARHGEF5 protein | CTD | PMID:35688186 | ARHGEF5 | Human | CGP 52608 | multiple interactions | EXP | | 6480464 | CGP 52608 promotes the reaction [RORA protein binds to ARHGEF5 gene] | CTD | PMID:28238834 | ARHGEF5 | Human | cyclosporin A | increases expression | EXP | | 6480464 | Cyclosporine results in increased expression of ARHGEF5 mRNA | CTD | PMID:20106945 and PMID:25562108 | ARHGEF5 | Human | DDE | decreases expression | EXP | | 6480464 | Dichlorodiphenyl Dichloroethylene results in decreased expression of ARHGEF5 mRNA | CTD | PMID:38568856 | ARHGEF5 | Human | Dibutyl phosphate | affects expression | EXP | | 6480464 | di-n-butylphosphoric acid affects the expression of ARHGEF5 mRNA | CTD | PMID:37042841 | ARHGEF5 | Human | diethylstilbestrol | increases expression | ISO | Arhgef5 (Rattus norvegicus) | 6480464 | Diethylstilbestrol results in increased expression of ARHGEF5 mRNA | CTD | PMID:21658437 | ARHGEF5 | Human | endosulfan | increases expression | ISO | Arhgef5 (Rattus norvegicus) | 6480464 | Endosulfan results in increased expression of ARHGEF5 mRNA | CTD | PMID:29391264 | ARHGEF5 | Human | epoxiconazole | decreases expression | ISO | Arhgef5 (Mus musculus) | 6480464 | epoxiconazole results in decreased expression of ARHGEF5 mRNA | CTD | PMID:35436446 | ARHGEF5 | Human | fenthion | decreases expression | ISO | Arhgef5 (Mus musculus) | 6480464 | Fenthion results in decreased expression of ARHGEF5 mRNA | CTD | PMID:34813904 | ARHGEF5 | Human | folic acid | multiple interactions | ISO | Arhgef5 (Mus musculus) | 6480464 | Folic Acid inhibits the reaction [1 and 2-Dimethylhydrazine results in increased expression of ARHGEF5 mRNA] | CTD | PMID:22206623 | ARHGEF5 | Human | FR900359 | increases phosphorylation | EXP | | 6480464 | FR900359 results in increased phosphorylation of ARHGEF5 protein | CTD | PMID:37730182 | ARHGEF5 | Human | methidathion | decreases expression | ISO | Arhgef5 (Mus musculus) | 6480464 | methidathion results in decreased expression of ARHGEF5 mRNA | CTD | PMID:34813904 | ARHGEF5 | Human | paracetamol | affects expression | ISO | Arhgef5 (Mus musculus) | 6480464 | Acetaminophen affects the expression of ARHGEF5 mRNA | CTD | PMID:17562736 | ARHGEF5 | Human | paracetamol | decreases expression | ISO | Arhgef5 (Rattus norvegicus) | 6480464 | Acetaminophen results in decreased expression of ARHGEF5 mRNA | CTD | PMID:33387578 | ARHGEF5 | Human | PCB138 | decreases expression | ISO | Arhgef5 (Rattus norvegicus) | 6480464 | 2 more ... | CTD | PMID:23829299 | ARHGEF5 | Human | pentachlorophenol | increases expression | ISO | Arhgef5 (Mus musculus) | 6480464 | Pentachlorophenol results in increased expression of ARHGEF5 mRNA | CTD | PMID:23892564 | ARHGEF5 | Human | perfluorohexanesulfonic acid | decreases expression | ISO | Arhgef5 (Mus musculus) | 6480464 | perfluorohexanesulfonic acid results in decreased expression of ARHGEF5 mRNA | CTD | PMID:37995155 | ARHGEF5 | Human | perfluorooctane-1-sulfonic acid | multiple interactions | ISO | Arhgef5 (Mus musculus) | 6480464 | [perfluorooctane sulfonic acid co-treated with Cellulose] results in increased expression of ARHGEF5 mRNA | CTD | PMID:36331819 | ARHGEF5 | Human | perfluorooctanoic acid | multiple interactions | ISO | Arhgef5 (Rattus norvegicus) | 6480464 | [Zeranol co-treated with perfluorooctanoic acid] results in decreased expression of ARHGEF5 mRNA | CTD | PMID:35163327 | ARHGEF5 | Human | phenobarbital | affects expression | EXP | | 6480464 | Phenobarbital affects the expression of ARHGEF5 mRNA | CTD | PMID:19159669 | ARHGEF5 | Human | quercetin | decreases phosphorylation | EXP | | 6480464 | Quercetin results in decreased phosphorylation of ARHGEF5 protein | CTD | PMID:35688186 | ARHGEF5 | Human | silicon dioxide | decreases expression | EXP | | 6480464 | Silicon Dioxide analog results in decreased expression of ARHGEF5 mRNA | CTD | PMID:25895662 | ARHGEF5 | Human | sodium arsenite | decreases expression | EXP | | 6480464 | sodium arsenite results in decreased expression of ARHGEF5 mRNA | CTD | PMID:22714537 | ARHGEF5 | Human | tetrachloromethane | increases expression | ISO | Arhgef5 (Mus musculus) | 6480464 | Carbon Tetrachloride results in increased expression of ARHGEF5 mRNA | CTD | PMID:31919559 | ARHGEF5 | Human | thioacetamide | increases expression | ISO | Arhgef5 (Rattus norvegicus) | 6480464 | Thioacetamide results in increased expression of ARHGEF5 mRNA | CTD | PMID:23411599 and PMID:34492290 | ARHGEF5 | Human | trimellitic anhydride | decreases expression | ISO | Arhgef5 (Mus musculus) | 6480464 | trimellitic anhydride results in decreased expression of ARHGEF5 mRNA | CTD | PMID:19042947 | ARHGEF5 | Human | triphenyl phosphate | affects expression | EXP | | 6480464 | triphenyl phosphate affects the expression of ARHGEF5 mRNA | CTD | PMID:37042841 | ARHGEF5 | Human | valproic acid | affects expression | ISO | Arhgef5 (Mus musculus) | 6480464 | Valproic Acid affects the expression of ARHGEF5 mRNA | CTD | PMID:17963808 | ARHGEF5 | Human | valproic acid | decreases expression | ISO | Arhgef5 (Rattus norvegicus) | 6480464 | Valproic Acid results in decreased expression of ARHGEF5 mRNA | CTD | PMID:29427782 | |